Intranasal GDNF for Parkinson's Disease: Next steps in preclinical development

被引：0
|
作者：
Waszczak, Barbara Lee [1 ]
Wachtman, Lynn [2 ]
Newsome, Ginnifer C. [2 ]
Aly, Amirah [1 ]
Silva, Nilsa [2 ]
Westmoreland, Susan [2 ]
Rowlett, James [2 ]
Migliore, Mattia M. [3 ]
机构：
[1] Northeastern Univ, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, New England Primate Res Ctr, Southborough, MA 01772 USA
[3] Massachusetts Coll Pharm & Hlth Sci, Boston, MA USA
来源：
FASEB JOURNAL | 2013年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
1177.10
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Gene therapy for Parkinson's disease: Disease modification by GDNF family of ligands
    Kirik, Deniz
    Cederfjall, Erik
    Halliday, Glenda
    Petersen, Asa
    NEUROBIOLOGY OF DISEASE, 2017, 97 : 179 - 188
  • [42] Combination therapy using GDNF and cell transplant in Parkinson's disease
    Xiao, Bin
    Zhang, Su-Chun
    Tan, Eng-King
    MOLECULAR NEURODEGENERATION, 2022, 17 (01)
  • [43] AAV delivery of human GDNF for treatment of Parkinson's disease (PD)
    West, NC
    Bohn, MC
    MOVEMENT DISORDERS, 2006, 21 : S64 - S64
  • [44] GDNF signaling in subjects with minimal motor deficits and Parkinson?s disease
    Chu, Yaping
    Kordower, Jeffrey H.
    NEUROBIOLOGY OF DISEASE, 2021, 153
  • [45] GDNF clinical trials for Parkinson’s disease: a critical human dimension
    Don Marshall Gash
    Greg A. Gerhardt
    Luke H. Bradley
    Renee Wagner
    John T. Slevin
    Cell and Tissue Research, 2020, 382 : 65 - 70
  • [46] AAV2-GDNF Gene Therapy for Parkinson's Disease
    Ram, Sharona Even
    Galun, Eithan
    HUMAN GENE THERAPY, 2009, 20 (05) : 430 - 431
  • [47] GDNF Family Ligands: A Potential Future for Parkinson's Disease Therapy
    Mickiewicz, Amanda L.
    Kordower, Jeffrey H.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2011, 10 (06) : 703 - 711
  • [48] GDNF treatment in Parkinson's disease: time for controlled clinical trials?
    Brundin, P
    BRAIN, 2002, 125 : 2149 - 2151
  • [49] GDNF in Parkinson's disease: The perils of post-hoc power
    Matcham, James
    McDermott, Michael P.
    Lang, Anthony E.
    JOURNAL OF NEUROSCIENCE METHODS, 2007, 163 (02) : 193 - 196
  • [50] COMPARISON OF GDNF-VARIANTS IN A RAT MODEL OF PARKINSON'S DISEASE
    Piltonen, Marjo
    Bespalov, Maxim M.
    Mannisto, Pekka T.
    BEHAVIOURAL PHARMACOLOGY, 2011, 22 : E45 - E45
12345